Tumor-informed patient-specific MRD monitoring analysis in colorectal cancer.

被引：0
|
作者：
Chen, Gong
Zeng, Yongming
Feng, Chunzai
Yang, Jingge
Cheng, Longqing
Wang, Hui
Xia, Ligang
Jiang, Mei
Wang, Xiaozhong
Zeng, Xiaoling
Tian, Zihan
Fu, Ning
Zhang, Xue
Cao, Wuqiang
Li, Pansong
Gao, Wei
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China
[2] Shantou Univ, Affiliated Hosp 1, Shantou, Peoples R China
[3] Zhongshan Peoples Hosp, Zhongshan, Peoples R China
[4] Jinan Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[5] First Peoples Hosp Foshan, Foshan, Peoples R China
[6] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China
[7] Shenzhen Peoples Hosp, Shenzhen, Peoples R China
[8] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou, Peoples R China
[9] Shantou Cent Hosp, Shantou, Peoples R China
[10] Geneplus Beijing Inst, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
48
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [1] Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for postoperative monitoring of patients with stages I-III colorectal cancer (CRC).
    Zhou, Jian
    Yang, Jian
    Zhang, Zixiang
    Li, Ye
    Yi, Bin
    Tang, Yuchen
    Li, Dechun
    Li, Xiaozhe
    Peng, Di
    Li, Xi
    Wang, Yang
    Li, Haiyan
    Li, Bing
    Wang, Chenyang
    Zhu, Pengfei
    Chen, Longfei
    Wu, Shuailai
    Fang, Shuai
    Li, Chenxi
    Qiu, Fujun
    Chuai, Shannon
    Zhang, Zhihong
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [2] Patient-specific tumor-informed circulating tumor DNA (ctDNA) assay to predict cancer recurrence in patients with resected pancreatic cancer.
    Wang, Xiuchao
    Wang, Hongwei
    Chen, Xinyun
    Liu, Yuxiao
    Zhao, Tiansuo
    Gao, Song
    Wang, Jian
    Ma, Weidong
    Gao, Chuntao
    Hao, Jihui
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 744 - 744
  • [3] Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in surgical patients with stage I-IV colorectal cancer (CRC).
    Cao, Di
    Wang, Fu-Long
    Li, Cong
    Zhang, Rong-Xin
    Wu, Xiao-Jun
    Li, Liren
    Lu, Zhen-Hai
    Pan, Zhi-Zhong
    Lin, Jun-zhong
    Wu, Miaoqing
    Liu, Yifan
    Lv, Guangzhao
    Li, Min
    Wang, Chenyang
    Li, Xi
    Chen, Gong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 213 - 213
  • [4] Accuracy of genome-wide mutational analysis for tumor-informed ctDNA-guided MRD monitoring in bladder cancer.
    Nordentoft, Iver
    Lindskrog, Sia Viborg
    Birkenkamp-Demtroder, Karin
    Gonzalez, Santiago
    Kuzman, Maja
    Glavas, Dunja
    Ptashkin, Ryan N.
    Smadbeck, James
    Afterman, Danielle
    Lauterman, Tomer
    Cohen, Yarin
    Donenhirsh, Zohar
    Tavassoly, Iman
    Alon, Ury
    Polak, Paz
    Oklander, Boris
    Agerbaek, Mads
    Jensen, Jorgen Bjerggaard
    Zviran, Asaf
    Dyrskjot, Lars
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] A patient-specific, tumor-informed, circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) assay in surgical patients with biliary tract cancer
    Song, Tianqiang
    Wu, Qiang
    Cui, Yunlong
    Li, Huikai
    Zhang, Wei
    Fang, Feng
    Xiong, Qingqing
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [6] Longitudinal tumor-informed ctDNA assay and patient outcomes in testicular cancer.
    Chehrazi-Raffle, Alex
    Laliotis, George
    Tillu, Neeraja
    Cumarasamy, Shivaram
    Rich, Jordan
    Manage, Kevin
    Sharma, Shruti
    Dutta, Punashi
    Malhotra, Meenakshi
    Elnaggar, Adam
    Liu, Minetta C.
    Rock, Adam
    Dorff, Tanya B.
    Sfakianos, John P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [7] Tumor-informed patient-specific panel outperforms tumor-naive and tumor-informed fixed panel for circulating tumor DNA (ctDNA)-based postoperative monitoring of non-small cell lung cancer (NSCLC).
    Chen, Kezhong
    Shen, Haifeng
    Wu, Shuailai
    Zhu, Pengfei
    Wang, Chenyang
    Lizaso, Analyn
    Kang, Guannan
    Wang, Yang
    Lv, Juan
    Fang, Shuai
    Wu, Wenjun
    Qiu, Fujun
    Sun, Yuan
    Lu, Qiang
    Zhao, Heng
    Chuai, Shannon
    Yang, Fan
    Zhang, Zhihong
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [8] Tumor-informed fixed and patient-specific panels for minimal residual disease (MRD) detection in early-stage NSCLC:a head-to-head comparison
    Zhang, Pengpeng
    Gong, Zetian
    Yu, Yue
    Wang, Xiaoxuan
    Ye, Lei
    Wang, Xiaoqiang
    Tang, Xuan
    Zhang, Chao
    Deng, Wanglong
    Song, Chao
    Xu, Qing
    Li, Yansong
    Wang, Wei
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [9] Individualized tumor-informed circulating tumor DNA analysis for molecular residual disease detection in predicting recurrence and efficacy of adjuvant chemotherapy in colorectal cancer.
    Cao, Di
    Zhou, Qiaoxia
    Fan, Xuning
    Yang, Jinyu
    Li, Cong
    Wang, Fulong
    Zhang, Rongxin
    Wu, Xiaojun
    Li, Liren
    Lu, Zhenhai
    Pan, Zhizhong
    Lin, Junzhong
    Wu, Miaoqing
    Liu, Yifan
    Lv, Guangzhao
    Qiu, Fujun
    Xin, Haoyang
    Xu, Yu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Exploration of Factors Affecting the Performance of MRD Tumor-Informed Assay in Chinese Lung Cancer Patients
    Lin, G.
    Wang, A.
    Li, F.
    Gu, P.
    Zhou, H.
    Yao, J.
    Wang, M.
    Liu, W.
    Zheng, X.
    Zheng, X.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S578 - S578
12345